請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72334
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 簡盟月(Meng-Yueh Chien) | |
dc.contributor.author | Ming-Ting Yang | en |
dc.contributor.author | 楊名廷 | zh_TW |
dc.date.accessioned | 2021-06-17T06:36:01Z | - |
dc.date.available | 2021-08-30 | |
dc.date.copyright | 2018-08-30 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-16 | |
dc.identifier.citation | 1. Chugh SS, Havmoeller R, Narayanan K, Mensah GA, Ezzati M, Murray CJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47.
2. Lip GY, Beevers DG. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ 1995;311:1361-3. 3. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European respective. Clin Epidemiol 2014;6:213-20. 4. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N. 5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. 6. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:2071-104. 7. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016;50:e1-e88. 8. Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation 2012;125:2933-43. 9. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res 2017;120:1501-17. 10. Waks JW, Josephson ME. Mechanisms of atrial fibrillation - reentry, rotors and reality. Arrhythm Electrophysiol Rev 2014;3:90-100. 11. Halmos PB, Patterson GC. Effect of atrial fibrillation on cardiac output. Br Heart J 1965;27:719-23. 12. Rodman T, Pastor BH, Figueroa W. Effect on cardiac output of conversion from atrial fibrillation to normal sinus mechanism. Am J Med 1966;41:249-58. 13. Skinner NS Jr, Mitchell JH, Wallace AG, Sarnoff SJ. Hemodynamic consequences of atrial fibrillation at constant ventricular rates. Am J Med 1964;36:342-50. 14. Guazzi M, Belletti S, Tumminello G, Fiorentini C, Guazzi MD. Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation. Am J Physiol Heart Circ Physiol 2004;287:H2899-905. 15. Guazzi M, Arena R. Endothelial dysfunction and pathophysiological correlates in atrial fibrillation. Heart 2009;95:102-6. 16. Donoghue OA, Jansen S, Dooley C, De Rooij S, Van Der Velde N, Kenny RA. Atrial fibrillation is associated with impaired mobility in community-dwelling older adults. J Am Med Dir Assoc 2014;15:929-33. 17. Sanders NA, Ganguly JA, Jetter TL, Daccarett M, Wasmund SL, Brignole M, et al. Atrial fibrillation: an independent risk factor for nonaccidental falls in older patients. Pacing Clin Electrophysiol 2012;35:973-9. 18. Hung CY, Wu TJ, Wang KY, Huang JL, Loh EW, Chen YM, et al. Falls and atrial fibrillation in elderly patients . Acta Cardiologica Sinica 2013;29:436-43. 19. Magnani JW, Wang N, Benjamin EJ, Garcia ME, Bauer DC, Butler J, et al. Atrial fibrillation and declining physical performance in older adults: The Health, Aging and Body Composition Study (Health ABC). Circ Arrhythm Electrophysiol 2016;9:e003525. 20. Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 2013;158:338-46. 21. Knecht S, Oelschläger C, Duning T, Lohmann H, Albers J, Stehling C, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 2008;29:2125-32. 22. Liao JN, Chao TF, Liu CJ, Wang KL, Chen SJ, Tuan TC, et al. Risk and prediction of dementia in patients with atrial fibrillation-a nationwide population-based cohort study. Int J Cardiol 2015;199:25-30. 23. Hui DS, Morley JE, Mikolajczak PC, Lee R. Atrial fibrillation: A major risk factor for cognitive decline. Am Heart J 2015;169:448-56. 24. Alonso A, Arenas de Larriva AP. Atrial fibrillation, cognitive decline and dementia. Eur Cardiol 2016;11:49-53. 25. Fumagalli S, Tarantini F, Guarducci L, Pozzi C, Pepe G, Boncinelli L, et al. Atrial fibrillation is a possible marker of frailty in hospitalized patients: results of the GIFA Study. Aging Clin Exp Res 2010;22:129-33. 26. Polidoro A, Stefanelli F, Ciacciarelli M, Pacelli A, Di Sanzo D, Alessandri C. Frailty in patients affected by atrial fibrillation. Arch Gerontol Geriatr 2013;57:325-7. 27. Heuberger RA. The frailty syndrome: a comprehensive review. J Nutr Gerontol Geriatr 2011;30:315-68. 28. Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet 1999;353:205-6. 29. Speechley M, Tinetti M. Falls and injuries in frail and vigorous community elderly persons. J Am Geriatr Soc 1991;39:46-52. 30. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34:2746-51. 31. Haim M, Hoshen M, Reges O, Rabi Y, Balicer R, Leibowitz M. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc 2015;4:e001486. 32. Chiang CE, Wu TJ, Ueng KC, Chao TF, Chang KC, Wang CC, et al. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation. J Formos Med Assoc 2016;115:893-952. 33. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010;31:967-75. 34. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’. Eur Heart J 2009;30:2969-77c. 35. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4: 369-82. 36. Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clin Cardiol 2017;40:413-8. 37. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657-63. 38. Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M, et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirintreated patients in ACTIVE-A and AVERROES. Eur Heart J 2015;36:281-87a. 39. Dobreanu D, Svendsen JH, Lewalter T, Hernández-Madrid A, Lip GY, Blomström-Lundqvist C. Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace 2013;15:1223-5. 40. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66. 41. Perez-Lugones A, McMahon JT, Ratliff NB, Saliba WI, Schweikert RA, Marrouche NF, et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:803-9. 42. El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, et al. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation 2006;114:670-80. 43. Vest JA, Wehrens XH, Reiken SR, Lehnart SE, Dobrev D, Chandra P, et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 2005;111:2025-32. 44. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959;58:59-70. 45. Aldhoon B, Melenovsky V, Peichl P, Kautzner J. New insights into mechanisms of atrial fibrillation. Physiol Res 2010;59:1-12. 46. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS) ; and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Heart Rhythm 2012;9:632-96. 47. Savelieva I, Kakouros N, Kourliouros A, et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines: part I: primary prevention. Europace 2011;13:308–28. 48. Wakili R, Voigt N, Kaab S, et al. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011;121:2955–68. 49. Abed HS, Samuel CS, Lau DH, Kalman JM, Wittert GA, Sanders P, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 2013;10:90-100. 50. Upshaw CB Jr. Hemodynamic changes after cardioversion of chronic atrial fibrillation. Arch Intern Med 1997;157:1070-6. 51. UC Irvine Institute for Memory Impairments and Neurological Disorders. Mild Cognitive Impairment. Available at: https://www.mind.uci.edu/dementia/mild-cognitive-impairment/. 2017. 06. 28. 52. Marzona I, O'Donnell M, Teo K, Gao P, Anderson C, Bosch J, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ 2012;184:E329-36. 53. Hahne K, Mönnig G, Samol A. Atrial fibrillation and silent stroke: links, risks, and challenges. Vasc Health Risk Manag 2016;12:65-74. 54. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22. 55. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 1995;92:2178-82. 56. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 2010;58:681-7. 57. Ahmed N, Mandel R, Fain MJ. Frailty: an emerging geriatric syndrome. Am J Med 2007;120:748-53. 58. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-56. 59. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59:255-63. 60. Morley JE. Frailty and sarcopenia: the new geriatric giants. Rev Invest Clin 2016;68:59-67. 61. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007;62A:722-7. 62. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle-aged African American. J Nutr Health Aging 2012;16:601-8. 63. Mlynarska A, Mlynarski R, Golba KS. Older age and a higher EHRA score allow higher levels of frailty syndrome to be predicted in patients with atrial fibrillation. Aging Male 2017;20:23-7. 64. Chen LJ, Chen CY, Lue BH, Tseng MY, Wu SC. Prevalence and associated factors of frailty among elderly people in Taiwan. Int J Gerontol 2014;8:114-9. 65. Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: A review. Eur J Intern Med 2016;31:3-10. 66. Rolfson D, Majumdar S, Tsuyuki R, Tahir A, Rockwood K. Validity and reliability of the Edmonton frail scale. Age Ageing 2006;35:526-9. 67. 內政部統計處人口數性別概況。取自:http://statis.moi.gov.tw/micst/stmain.jsp?sys=220&ym=10605&ymt=10705&kind=21&type=1&funid=c0110102&cycle=41&outmode=0&compmode=0&outkind=1&fldlst=1111&cod00=1&cod03=1&rdm=iiKnYmlj,取得日期:2018. 6. 21。 68. Chien KL, Su TC, Hsu HC, Chang WT, Chen PC, Chen MF, et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol 2010;139:173-80. 69. Misialek JR, Rose KM, Everson-Rose SA, Soliman EZ, Clark CJ, Lopez FL, et al. Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study. J Am Heart Assoc 2014;3. pii: e001159. 70. Santos AC, Ebrahim S, Barros H. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health 2008;8:62. 71. Parson JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 2010;5:212-8. 72. Di Monaco M, Di Monaco R, Manca M, Cavanna A. Handgrip strength is an independent predictor of distal radius bone mineral density in postmenopausal women. Clin Rheumatol 2000;19:473-6. 73. Gale CR, Martyn CN, Cooper C, Sayer AA. Grip strength, body composition, and mortality. Int J Epidemiol 2007;36:228-35. 74. Massy-Westropp NM, Gill TK, Taylor AW, Bohannon RW, Hill CL. Hand grip strength: age and gender stratified normative data in a population-based study. BMC Res Notes 2011;4:127. 75. Kozakai R, Ando F, Kim HY, Yuki A, Otsuka R, Shimokata H. Sex-difference in age-related grip strength decline: a 10-year longitudinal study of community-living middle-aged and older Japanese. J Phys Fitness Sport Med 2016;5:87-94. 76. Poole-Wilson PA, Buller NP, Lipkin DP. Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure. Am J Cardiol 1988;62:49E-52E. 77. Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act 2015;23:314-22. 78. Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simonsick EM, Newman AB, et al. Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2005;53:1675-80. 79. Fritz S, Lusardi M. White paper: 'walking speed: the sixth vital sign'. J Geriatr Phys Ther 2009;32:46-9. 80. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 2014;15:95-101. 81. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009;13:881-9. 82. Bohannon RW. Reference values for the timed up and go test: a descriptive meta analysis. J Geriatr Phys Ther 2006;29:64-8. 83. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopedic Surgeons panel on falls prevention. Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001;49:664-772. 84. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther 2000;80:896-903. 85. Chen CY, Wu SC, Chen LJ, Lue BH. The prevalence of subjective frailty and factors associated with frailty in Taiwan. Arch Gerontol Geriatr 2010;50:S43-7. 86. Ng TP, Feng L, Nyunt MS, Larbi A, Yap KB. Frailty in older persons: multisystem risk factors and the Frailty Risk Index (FRI). J Am Med Dir Assoc 2014;15:635-42. 87. Sergi G, Veronese N, Fontana L, De Rui M, Bolzetta F, Zambon S, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study. J Am Coll Cardiol 2015;65:976-83. 88. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15:548-61. 89. Libon DJ, Malamut BL, Swenson R, Sands LP, Cloud BS . Further analyses of clock drawings among demented and nondemented older subjects. Arch Clin Neuropsychol 1996;11:193-205. 90. Ricci M, Pigliautile M, D'Ambrosio V, Ercolani S, Bianchini C, Ruggiero C, et al. The clock drawing test as a screening tool in mild cognitive impairment and very mild dementia: a new brief method of scoring and normative data in the elderly. Neurol Sci 2016;37:867-73. 91. Brodaty H, Moore CM. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic. Int J Geriatr Psychiatry 1997;12:619-27. 92. Brigola AG, Rossetti ES, Dos Santos BR, Neri AL, Zazzetta MS, Inouye K, et al. Relationship between cognition and frailty in elderly: A systematic review. Dement Neuropsychol 2015;9:110-9. 93. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015;24:637-46. 94. Saum KU, Schöttker B, Meid AD, Holleczek B, Haefeli WE, Hauer K, Brenner H. Is polypharmacy associated with frailty in older people? results from the ESTHER cohort study. J Am Geriatr Soc 2017;65:e27-e32. 95. Pulignano G, Del Sindaco D, Tinti MD, Di Lenarda A, Alunni G, Senni M, et al. Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patients. J Cardiovasc Med 2016;17:616-23. 96. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr 2008;8:24. 97. Chelu MG, Gunderson BD, Koehler J, Ziegler PD, Sears SF. Patient Activity Decreases and Mortality Increases After the Onset of Persistent Atrial Fibrillation in Patients with Implantable Cardioverter-Defibrillators. JACC Clin Electrophysiol 2016;2:518-23. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72334 | - |
dc.description.abstract | 研究背景與目的:心房顫動(atrial fibrillation, AF)為臨床最常見之心律不整。過去針對住院病人進行的研究指出,心房顫動除了本身疾病對病患生理功能的負擔外,還會對患者造成其他影響,包括病人住院期間變長、衰弱比例增高,以及出院後六個月內死亡率較高等;而社區調查也發現心房顫動長者的認知功能、功能性測驗,以及行走速度都相較同年齡健康者差。然而過去探討社區老人心房顫動對身體功能影響的文獻不足,更缺乏心房顫動與衰弱相關性之探討。鑑於人口老化及心房顫動的盛行率逐年提高,本研究將探討社區老人心房顫動與衰弱之相關性。研究方法:本研究採用橫斷面設計,受試者來源為台大醫院內科門診與大台北地區有意願參與研究的65歲以上老人。受試者需接受心電圖檢查或醫師診斷,判斷是否為心房顫動。評估項目包括:身體功能評估(握力、五公尺步行所需時間,與計時起走測驗)、臺灣版國際身體活動量問卷(international physical activity questionnaire, IPAQ, Taiwan version)、心血管健康研究(cardiovascular health study, CHS)衰弱評估,以及Edmonton衰弱問卷(Edmonton frail scale)。統計分析使用SPSS第18版(SPSS Inc, Version 18.0. Chicago: SPSS Inc.)進行分析。分別利用獨立樣本t檢定(independent t test)與卡方檢定分析(chi square analysis)比較有無心房顫動兩組受試者與不同嚴重程度心房顫動患者組內的連續性數值與類別資料差異,再以多邏輯迴歸(multiple logistic regression)分析心房顫動與衰弱程度的關聯性。所有顯著信賴水準定為0.05。研究結果:本實驗一共徵收207位社區長者,38位為心房顫動患者。心房顫動組和心律規律組相比,男性握力(26.76 ± 8.25與32.96 ± 6.85公斤)、五公尺步行所需時間(5.06 ± 1.47與4.42 ± 1.06秒)、每秒步行速度(1.05 ± 0.25與1.19 ± 0.25公尺/秒)、計時起走測驗(8.82 ± 2.44與7.04 ± 1.94秒),以及CHS衰弱評估之非健壯人數百分比依臺灣常模(50%與24%)和美國常模(69%與36%)皆有顯著組間差異。CHS衰弱評估中,心房顫動組的肌力下降人數百分比(47%與26%)和低身體活動量人數百分比(21%與8%),顯著較心律規律組高。Edmonton衰弱問卷中,心房顫動組的認知測驗答錯人數百分比(39%與25%)、過去一年住院次數(26%與9%)與使用多重藥物百分比(42%與17%),顯著較心律規律組高。迴歸分析顯示心房顫動是預測社區非健壯長者的獨立影響因子(勝算比:3.84,95%信賴區間:1.81 – 8.14)。依據實驗時心律做子群分析,實驗時心房顫動組和實驗室時竇性組相比,男性握力(24.39 ± 8.80與32.64 ± 6.91公斤)、五公尺步行測驗(5.40 ± 1.76與4.44 ± 1.02秒)、以及計時起走測驗(9.37 ± 3.01與7.12 ± 1.90秒),皆顯著較差且組間差距增加。此外,迴歸分析顯示實驗時心房顫動與社區非健壯長者的勝算比提高至5.59(1.97 – 15.81)。結論:心房顫動患者與心律規則的社區長者相比,多項身體功能測驗以及衰弱程度分佈有顯著差異 ; 此外心房顫動是預測社區非健壯長者的獨立影響因子。但本研究心房顫動合併衰弱的人數較少,未來仍須更大樣本數的研究探討心房顫動與社區長者衰弱的關聯性。 | zh_TW |
dc.description.abstract | Background and purpose: Atrial fibrillation (AF) is the most common arrhythmias. Besides the disease burden itself, research investigating hospitalized patients have indicated there are deleterious effects of AF, including longer stay days for hospitalization, higher rates of frailty and increasing mortality rate after discharged in six months. Few research found that elderly with AF had lower cognitive function, physical function and slower walking speed compared with the health ones in community. However, there is only limited articles investigating the impact of AF on physical function of community-dwelling elderly, and the relationship between AF and frailty is also lack of discussion. According to the aging society and increasing prevalence of both AF and frailty, this research would investigate the relationship between AF and frailty in community-dwelling elderly. Methods: The study was a cross-sectional study. Subjects older than 65 years old were recruited from clinics of department of internal medicine, in National Taiwan University and communities in Taipei. All the subjects from community underwent the test of ECG to measure AF. Patients from the clinic were allocated to AF group based on the diagnosis history. Assessment items included physical function (grip strength, time spent for five-meter walk test, and timed up and go test), international physical activity questionnaire (IPAQ) Taiwan version, CHS frailty assessment, and Edmonton frail scale. SPSS version 18.0 (SPSS Inc, Version 18.0. Chicago: SPSS Inc.) was used for statistical analysis. The independent t test and chi square analysis were used to examine the difference of continuous and categorical data between groups, respectively. Then the multiple logistic regression was used to examine the correlation between AF and frailty. All the significant levels were set at 0.05. Results: The study included 207 community-dwelling elderly, 38 of them were patients with AF. Compared with regular heart rhythm group, there were significant differences in grip strength of male subjects (26.76 ± 8.25 vs 32.96 ± 6.85 kilogram), time spent for five-meter walking test (5.06 ± 1.47 vs 4.42 ± 1.06 seconds), walk speed (1.05 ± 0.25 vs 1.19 ± 0.25 meter/second), timed up and go test (8.82 ± 2.44 vs 7.04 ± 1.94 seconds), and the percentage of the numbers of non-robust subjects among groups based on the CHS frailty assessment criteria of Taiwan (50% vs 24%) and US (69% vs. 37%) in AF group. There were significant higher percentage of the numbers in weakness (47% vs 26%) and low level of physical activity (21% vs 8%) in AF group in CHS frailty assessment. In Edmonton frail scale, there were significant higher percentage of the number in making mistake in the question of cognitive domain (39% vs 25%), number of been admitted to hospital (26% vs 9%) and use more than 5 or more different medication (42% vs 17%) in AF group. The multiple logistic regression model showed that AF was an independent predictor for non-robust community-dwelling elderly (odds ratio: 3.84, 95% confidence interval: 1.81 - 8.14) in community-dwelling elderly. Subgroup analysis found the larger differences in grip strength of male subjects (24.39 ± 8.80 vs 32.64 ± 6.91 kilogram), time spent for five-meter walking test (5.40 ± 1.76 vs 4.44 ± 1.02 seconds), and timed up and go test (9.37 ± 3.01 vs 7.12 ± 1.90 seconds). Furthermore, the multiple logistic regression model showed that the odds ratio of During-AF raised to 5.59 (95% confidence interval: 1.97 - 15.81). Conclusions: Compared with the community-dwelling elderly with regular heart rhythm, there were significant difference in several physical function and frailty status in patients with AF. Also, AF was an independent predictor of non-robust community-dwelling elderly. However, the number of patients with AF combined frailty is few in the research, future studies are needed to recruit larger samples to examine the relationship between AF and frailty. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T06:36:01Z (GMT). No. of bitstreams: 1 ntu-107-R05428004-1.pdf: 2065854 bytes, checksum: d05599380347ecf8eb4424c54c02d9cb (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 致謝 I
中文摘要 II ABSTRACT IV 第一章、前言 5 第一節、研究背景與動機 5 第二節、研究目的 6 第三節、研究假說 7 第四節、變項定義 8 第五節、研究的重要性 9 第二章、文獻回顧 10 第一節、心房顫動 10 第二節、心房顫動的病理機轉 12 第三節、心房顫動的血液動力學 14 第四節、心房顫動與身體功能 15 第五節、心房顫動與認知功能 16 第六節、衰弱症候群 18 第七節、心房顫動與衰弱 19 第三章、研究設計與方法 21 第一節、研究設計 21 第二節、受試者 21 第三節、研究步驟 21 第四節、測量工具與測試方法 22 第五節、統計分析 24 第四章、研究結果 25 第一節、研究流程 25 第二節、受試者人口學資料與疾病 25 第三節、受試者身體功能表現 26 第四節、受試者衰弱程度分佈 27 第五節、心房顫動與衰弱程度的相關性 28 第六節、子群分析 29 第五章、討論 31 第一節、受試者人口學資料 31 第二節、心房顫動患者的身體功能表現 32 第三節、心房顫動患者的衰弱程度分佈 35 第四節、心房顫動與社區長者衰弱程度的關聯性 38 第五節、CHS與EDMONTON衰弱評估對於心房顫動長者應用性比較 39 第六節、不同類型心房顫動對長者的影響 40 第七節、本研究之限制 41 第六章、結論 43 參考資料 44 圖一、研究流程圖 54 圖二、醫院受試者分組流程圖 55 圖三、社區受試者分組流程圖 56 表一、心房顫動與身體功能文獻整理 57 表二、心房顫動與衰弱文獻整理 58 表三、受試者人口學資料 60 表四、受試者共病症調查 61 表五、身體功能表現與衰弱評估分數 62 表六、心房顫動患者身體功能表現與衰弱評估分數 63 表七、衰弱程度分佈 64 表八、心房顫動患者衰弱程度分佈 65 表九、CHS衰弱評估臺灣與美國切點比較 66 表十、 EDMONTON衰弱問卷答題情形 67 表十一、心房顫動與社區非健壯長者的關聯性 69 表十二、依據實驗時心律分組的人口學資料 70 表十三、依據實驗時心律分組的共病症調查 71 表十四、依據實驗時心律分組的身體功能表現和衰弱評估分數 72 表十五、依據實驗時心律分組的的衰弱程度分佈 73 表十六、依據實驗時心律分組的CHS衰弱評估臺灣與美國切點比較 74 表十七、依據實驗時心律分組的EDMONTON衰弱問卷答題情形 75 表十八、實驗時心房顫動與社區非健壯長者的關聯性 77 附錄一、臺灣大學醫學院倫委會審查通過證明 78 附錄二、受試者基本資料表 81 附錄三、CHS衰弱評估美國標準 83 附錄四、CHS衰弱評估臺灣標準 84 附錄五、臺灣版國際身體活動量短版問卷 85 附錄六、EDMONTON衰弱問卷 89 | |
dc.language.iso | zh-TW | |
dc.title | 社區老人心房顫動與衰弱相關性之研究 | zh_TW |
dc.title | The Relationship between Atrial Fibrillation and Frailty in Community-Dwelling Elderly | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 曹昭懿(Jau-Yih Tsauo),吳彥雯(Yen-Wen Wu),詹鼎正(Ding-Cheng Chan) | |
dc.subject.keyword | 心房顫動,身體功能,衰弱,衰弱表現型,Edmonton衰弱問卷,社區老年人, | zh_TW |
dc.subject.keyword | Atrial fibrillation,Physical function,Frailty,Frailty phenotype,Edmonton frail scale,Community-dwelling elderly, | en |
dc.relation.page | 90 | |
dc.identifier.doi | 10.6342/NTU201803055 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-16 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 物理治療學研究所 | zh_TW |
顯示於系所單位: | 物理治療學系所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 2.02 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。